INTEST CORP — Form 8-K
Filed July 31, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 52/100
What the filing says
InTest reported Q2 2026 revenue of ~$35M (vs. $32–34M guidance), beating expectations, but gross margin fell to ~40% (vs. 45% guided) due to Alfamation project mix headwinds (340 bps) and a $2M ITS supply-chain shipping delay (160 bps). The company discovered a $750K inventory overstatement in Q1 via a new ERP implementation issue at Alfamation, requiring a 220 bps downward Q1 gross-margin revision; management deemed the error immaterial to Q1 but material to current-period cumulative effect and disclosed a material weakness in internal controls (expected remediated by year-end). Full-year 2026 guidance was raised to $135–140M revenue (vs. prior $130–135M) and ~43% gross margin (vs. prior 45%), reflecting strong demand despite margin pressures.
Why this rating
Revenue beat and FY raise are positive, but material ERP control failure, $750K restatement, two consecutive quarters of margin underperformance (Alfamation), and forward margin guidance cut represent meaningful operational/reporting red flags for an $85M company. Mixed signal.
See more from July 31, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.